Is Cabometyx (cabozantinib) a chemotherapy drug?
Medically reviewed by N. France, BPharm. Last updated on Nov 30, 2020.
Cabometyx (cabozantinib) is a chemotherapy drug that is used to treat patients with advanced renal cell carcinoma (kidney cancer) and patients with hepatocellular carcinoma (liver cancer) who have previously been treated with Nexavar (sorafenib). It is taken once daily.
It is a small molecule chemotherapeutic drug that comes in three different strength yellow tablets including a:
- 60 mg oval tablet
- 40 mg triangular tablet
- 20 mg round tablet
Cabometyx is a tyrosine kinase inhibitor, which works by helping to stop the out-of-control growth that cancer cells display.
- Food and Drug Administration (FDA). Cabometyx. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208692s008lbl.pdf. [Accessed December 1, 2020].
Related Medical Questions
- How long do you take Cabometyx (cabozantinib) for?
- How does Cabometyx (cabozantinib) work?
- What is the difference between Cabometyx and Cometriq?
- How long does Opdivo prolong life and what’s its success rate?
- What is the success rate of Keytruda?
- How long does Opdivo (nivolumab) take to work and how do you know if it is working?
- What is the difference between Opdivo and Keytruda?